Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bristol-Myers Squibb Co (BMY) vs Wells Fargo & Co (WFC) Price & Performance

Bristol-Myers Squibb CoTrade
Wells Fargo & CoTrade

Price performance (Past 24H)

Key statistics

Bristol-Myers Squibb Co vs Wells Fargo & Co — how do they compare? Bristol-Myers Squibb Co trades at $63.65 (market cap $129.94B), while Wells Fargo & Co trades at $87.35 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 2× Bristol-Myers Squibb Co's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.

BMYWFC
Market Cap
$129.94B$264.66B
Sector
HealthFinancials
52-Week High
$65.89$96.40
52-Week Low
$42.60$73.42
Enterprise Value
$163.92B
Dividend Yield
3.96%2.29%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Read more on BMY

About Wells Fargo & Co

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

Read more on WFC